Abstract: Provided are novel silane derived compounds. Also provided are OLEDs and related consumer products that contain these novel silane derived compounds. Further provided are formulations comprising these novel silane derived compounds.

Abstract: An enclosure for an electronic device includes a metal substrate, a porous anodic oxide layer overlaying the metal substrate, and a hydrothermal sealant disposed on the anodic oxide layer, the hydrothermal sealant including a molten salt.

Abstract: A compound is disclosed that has a metal coordination complex structure having at least two ligands coordinated to the metal; wherein the compound has a first substituent R1 at one of the ligands' periphery; wherein a first distance is defined as the distance between the metal and one of the atoms in R1 where that atom is the farthest away from the metal among the atoms in R1; wherein the first distance is also longer than any other atom-to-metal distance between the metal and any other atoms in the compound; and wherein when a sphere having a radius r is defined whose center is at the metal and the radius r is the smallest radius that will allow the sphere to enclose all atoms in the compound that are not part of R1, the first distance is longer than the radius r by at least 2.9 ?.

Abstract: A high-voltage winding (130) includes a winding body (1310), a high-voltage coil (1320), and a high-voltage insulating layer (1330). A wire is wound on the winding body (1310) to form the high-voltage coil (1320), and the high-voltage insulating layer (1330) is wrapped around the high-voltage coil (1320) and the winding body (1310).

Abstract: Provided are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein the variables in Formula (I) are as defined herein; and methods for their use and production.

Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.

Abstract: Provided are compounds of formula Ir(L1)x(L2)y(L3)z where L1 has L1 forms a 5-membered chelate ring with Ir; and L2 and L3 can be the same or different and have

Abstract: Provided are compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein the variables in Formula (I) are as defined herein; and methods for their use and production.

Abstract: This invention discloses iridium complexes containing phenylpyridine ligand wherein there is an aryl or heterocyclic ring fused into phenyl ring. The iridium complexes showed desired device performance.

Abstract: Provided are phenylthienothiazole containing compounds. The compound of the present invention comprises a first phenylthienothiazole-derived ligand LA according to Formula I as described herein which is coordinated to Ir to form a 5-membered chelate ring. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a ligand LA, having a structure of Formula I, is provided. In Formula I, A1 to A8 are each independently CR or N; at least two adjacent ones of A1 to A8 are CR and the Rs are joined together to form a six-membered ring fused to ring A or ring C; X is O, S, or Se; each R and RB is independently hydrogen or a substituent; any adjacent substituents are optionally joined or fused into a ring; the ligand LA is coordinated to a metal M; the metal M is bonded to ring A through a M-C bond; the metal M can be coordinated to other ligands; and the ligand LA is optionally linked with other ligands. Formulations, OLEDs, and consumer products containing such compounds are also disclosed.

Abstract: A composition is disclosed that includes a first compound capable of functioning as a host in an emissive layer of an OLED at room temperature; and a second compound that includes a ligand LA of Formula III where ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; where R represents two adjacent substituents that are joined together to form a ring that is fused to ring B, and R has a structure of Formula IV or Formula V disclosed herein.

Abstract: A winding body (1310) for a high-voltage winding (130) includes: a plurality of winding plates (1313), each of the winding plates (1313) being provided with a plurality of winding grooves (1314) to form a plurality of comb teeth on the winding plate (1313); and at least one auxiliary member (5316), the auxiliary member (5316) being ring-shaped, the winding plates (1313) being arranged along a circumferential direction of the auxiliary member (5316), and the auxiliary member (5316) being fixedly connected to the winding plates (1313). A high-voltage winding (130) includes: the foregoing winding body (1310); a high-voltage coil (1320); and a high-voltage insulating layer (1330). A dry-type transformer (10) includes a core (110), a low-voltage winding (120), and the foregoing high-voltage winding (130). The low-voltage winding (120) is sleeved outside the core (110), and the high-voltage winding (130) is sleeved outside the low-voltage winding (120).

Abstract: Some pathological conditions are accompanied by the increase in dimers of free light chains (FLCs) kappa and/or lambda. For instance, high levels of FLC dimers are found in AL amyloidosis, multiple myeloma, and multiple sclerosis. There is thus a need for sensitive methods that could specifically and quantitatively measure the amount of FLC dimers in a sample. The present application relates to a method for detecting and quantifying immunoglobulin FLC dimers in a sample that comprises subjecting the sample to proteolytic digestion under non-reducing conditions and subjecting the digested sample to mass spectrometry analysis to detect immunoglobulin free light chain dimer peptides. The method may be useful for diagnosis and monitoring of diseases characterized by the aberrant production of FLCs, such as plasma cell discrasias. Light-chain deposition disease (LCDD), autoimmune diseases, chronic kidney disease (CKD), and inflammatory conditions.

Abstract: This invention relates to the development of heterocyclic materials with high triplet excitation energy, which can be used as host materials in electroluminescent devices such as a PHOLED. The materials improve the performance of such devices by enhancing the lifetime and efficiency of the device when the newly developed heterocyclic materials are utilized as a host.

Abstract: The present invention includes a novel series of host materials for OLEDs based on substituted fused 1,2,4-triazines, represented by Formula I. The invention also includes an organic light-emitting device comprising an anode, a cathode, and an organic layer, disposed between the anode and the cathode, comprising a compound of Formula I. The compounds of the invention may improve the device EQE and lifetime.

Abstract: A system for multi-factor user authentication for payment card-based transactions are described. The multifactor authentication may be based on a one-time passcode/password (OTP) as sent by an authentication server. A user device may, based on receiving the OTP, send an authentication code. The authentication code may be generated/determined based on the OTP. The authentication code may be augmented biometric identifier (ID) of a user associated with the user device. The authentication server may validate a transaction based on the authentication code.

Abstract: In general, the disclosure is directed to bulk iron-nitride materials having a polycrystalline microstructure having pores including a plurality of crystallographic grains surrounded by grain boundaries, where at least one crystallographic grain includes an iron-nitride phase including any of a body centered cubic (bcc) structure, a body centered tetragonal (bct), and a martensite structure. The disclosure further describes techniques producing a bulk iron-nitride material having a polycrystalline microstructure, including: melting an iron source to obtain a molten iron source; fast belt casting the molten iron source to obtain a cast iron source; cooling and shaping the cast iron source to obtain a bulk iron-containing material having a body-centered cubic (bcc) structure; annealing the bulk iron-containing material at an austenite transformation temperature and subsequently cooling the bulk iron-containing material; and nitriding the bulk iron-containing material to obtain the bulk iron-nitride material.

Abstract: A compound having the formula Ir(LA)n(LB)3-n is disclosed wherein LA is an aza-DBF ligand and LB is an alkyl-substituted phenylpyridine ligand, wherein the compound has a structure according to Formula I: wherein each of A1 to A8 comprise carbon or nitrogen; wherein at least one of A1 to A8 is nitrogen; wherein ring B is bonded to ring A through a C—C bond; wherein the iridium is bonded to ring A through a Ir—C bond; wherein X is O, S, or Se; wherein R? and R? each independently represent mono-, di-substitution, or no substitution; wherein any adjacent substitutions in R?, R?, R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring; wherein R1, R2, R?, and R? are each independently selected from a variety of substituents; wherein R3, R4, R5, and R6 are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; wherein n is an integer from 1 to 3; and wherein total number of carbons in at least one of the pairs R3 and R4, and

Abstract: The present disclosure specifically discloses a substation frame, comprising: at least two supporting assemblies arranged at intervals along a first direction, at least one of the supporting assemblies comprising a first supporting part and a second supporting part that are connected to each other; and a beam assembly provided between two adjacent supporting assemblies. The first supporting part is located between the beam assembly and the second supporting part. The first supporting part is made of composite insulating material, and the second supporting part is made of metal material.